FDA Office of Generic Drugs
FDA named two directors for the Divisions of Chemistry I and II, Rashmi Patel and Michael Beatrice. Patel has been a branch chief in the office since 1987. Beatrice is the acting director of the Division of Product Certification in the Center for Biologics Evaluation and Research. Beatrice will not start his new position until December. Robert Jerussi, PhD, has been acting director for the chemistry divisions since the office reorganized in October 1990. Jerussi will assume the position of Associate Director for Chemistry,and Thomas Poux, who was Jerussi's acting deputy director, will return to head the ANDA Labeling Review Branch.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth